aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
NovaScan's mission is to revolutionize cancer detection with its breakthrough technology, offering solutions that require no capital equipment, are not size-constrained, and provide instantaneous, highly accurate results. Founded by a former Dean of the Engineering school at the University of Wisconsin Milwaukee, NovaScan aims to make cancer detection more accessible and efficient.
NovaScan has achieved significant milestones in the medical technology field, gaining recognition for its innovative approach to cancer detection. Its impact is marked by the potential to transform diagnostic procedures, reducing costs and improving patient outcomes.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Cancer Detection
Technology
Analytics
Tags
Biotech, Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was NovaScan founded?
NovaScan was founded in 2003.
Where is NovaScan’s headquarters located?
NovaScan’s headquarters is located in Chicago, IL, US.
When was NovaScan’s last funding round?
NovaScan’s most recent funding round was for $3M (USD) in January 2021.
How many employees does NovaScan have?
NovaScan has 30 employees as of Feb 4, 2024.
How much has NovaScan raised to-date?
As of July 05, 2023, NovaScan has raised a total of $7.5M (USD) since Jan 22, 2021.
Add Comparison
Total Raised to Date
$7.5M
USD
Last Update Jan 22, 2021
Last Deal Details
$3M
USD
Jan 22, 2021
Convertible Note
Total Employees Over Time
30
As of Feb 2024
NovaScan Address
222 Merchandise Mart Plaza
Suite 1230
Chicago,
Illinois
60654
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts